UCTH Breast Cancer Dataset
Research Hypothesis: This study hypothesizes that there are significant associations between the diagnostic characteristics of patients, including age, menopause status, tumor size, presence of invasive nodes, affected breast, metastasis status, breast quadrant, history of breast conditions, and their breast cancer diagnosis result. Data Collection and Description: The dataset of 213 patient observations was obtained from the University of Calabar Teaching Hospital cancer registry over 24 months (January 2019–August 2021). The data includes eleven features: year of diagnosis, age, menopause status, tumor size in cm, number of invasive nodes, breast (left or right) affected, metastasis (yes or no), quadrant of the breast affected, history of breast disease, and diagnosis result (benign or malignant). Notable Findings: Upon preliminary examination, the data shows variations in diagnosis results across different patient features. A noticeable trend is the higher prevalence of malignant results among patients with larger tumor sizes and the presence of invasive nodes. Additionally, postmenopausal women seem to have a higher rate of malignant diagnoses. Interpretation and Usage: The data can be analyzed using statistical and machine learning techniques to determine the strength and significance of associations between patient characteristics and breast cancer diagnosis. This can contribute to predictive modeling for the early detection and diagnosis of breast cancer. However, the interpretation must consider potential limitations, such as missing data or bias in data collection. Furthermore, the data reflects patients from a single hospital, limiting the generalizability of the findings to wider populations. The data could be valuable for healthcare professionals, researchers, or policymakers interested in understanding breast cancer diagnosis factors and improving healthcare strategies for breast cancer. It could also be used in patient education about risk factors associated with breast cancer.